AMGN

Amgen Inc. News Headlines

$115.54
*  
0.54
 negative 
0.47%
Get AMGN Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Good News for Celgene's Pipeline - Analyst Blog
7/16/2012 4:46:52 PM - Zacks.com

Merck Osteoporosis Candidate Scores - Analyst Blog
7/13/2012 6:46:43 PM - Zacks.com

Better Investors: Men or Women?
7/13/2012 9:46:21 AM - Cabot Heritage Corporation

New Highs, New Lows, Yield Greed
7/12/2012 3:16:30 AM - SeekingAlpha

After Hours Most Active for Jul 11, 2012 : LSI, FCX, PSEC, PHM, BAC, FB, ACC, WM, QCOM, AMGN, ACWI, SBAC
7/11/2012 4:43:55 PM - NASDAQ.com News

Merck KGaA's Erbitux Disappoints - Analyst Blog
7/10/2012 6:47:02 PM - Zacks.com

Amgen Acquires KAI - Analyst Blog
7/9/2012 4:00:01 PM - Zacks.com

FDA Label Expansion for Erbitux - Analyst Blog
7/9/2012 9:48:14 AM - Zacks.com

DaVita to Settle Epogen Lawsuit - Analyst Blog
7/6/2012 10:46:42 AM - Zacks.com

Amgen's Sensipar Disappoints - Analyst Blog
6/11/2012 10:45:01 AM - Zacks.com

Dr. Reddy's & Merck Serono Team Up - Analyst Blog
6/8/2012 6:48:01 PM - Zacks.com

Abbott Presents Data on Humira - Analyst Blog
6/7/2012 9:51:09 AM - Zacks.com

Positive Data on Roche's Avastin - Analyst Blog
6/5/2012 2:51:43 PM - Zacks.com

ETF Showdown: Calling On Convertibles (CWB, CVRT)
6/1/2012 2:57:43 AM - Benzinga

Amgen Presents Oncology Data - Analyst Blog
5/17/2012 5:30:01 PM - Zacks.com

Merck KGaA's Erbitux Faces Hurdle - Analyst Blog
5/17/2012 1:38:58 PM - Zacks.com

Amgen Beats but Maintains Outlook - Analyst Blog
4/25/2012 9:50:36 AM - Zacks.com

Amgen Q1 Profit and Revenue Beat Expectations (AMGN)
4/24/2012 4:50:17 PM - Dividend.com

Stocks On the Rebound, Dow Eyes Potential Head-and-Shoulders Support
4/24/2012 8:25:33 AM - Schaeffer's Investment Research

Dow Takes Back 13,000, But Can't Reclaim Key Trendline Support
4/20/2012 4:25:44 PM - Schaeffer's Investment Research

Dow Takes Back 13,000, But Can't Reclaim Key Trendline Support
4/20/2012 4:25:44 PM - Schaeffer's Investment Research

Earnings Preview: Amgen - Analyst Blog
4/19/2012 12:48:59 PM - Zacks.com

Earnings Preview: Abbott Labs - Analyst Blog
4/17/2012 9:49:24 AM - Zacks.com

The Zacks Analyst Blog Highlights: The Goldman Sachs Group, Lloyd's, Bank of America, JPMorgan Chase and Amgen - Press Releases
4/12/2012 9:09:54 AM - Zacks.com

Amgen Reaches for KAI Pharma - Analyst Blog
4/11/2012 4:57:01 PM - Zacks.com